BiotechTube
Home/NKGEN Biotech/James Graf
JG

James Graf

CFO (interim)

NKGEN Biotech

Therapeutic Areas

OncologyNeurodegenerative Diseases

NKGEN Biotech Pipeline

DrugIndicationPhase
SNK Cell TherapyOncological and Neurodegenerative DiseasesPhase 1

Leadership Team at NKGEN Biotech

PY
Paul Y. Song, MD
Chairman and Chief Executive Officer
YM
Yong Man Kim, PhD
Chief Scientific Officer
View full NKGEN Biotech profile